Inventor · disambiguated record
Cynthia Aki
Also filed as: AKI CYNTHIA J
9 granted patents·8 pending applications·186 citations·filing 1999–2011
88Inventor score
Top patents by PatentIndex Score
17 records- 0196US6372747B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Apr 16, 2002·93 cites·20 claims
- 0294US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0388US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 0488US7947720B23,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2009·Granted May 24, 2011·10 cites·4 claims
- 0583US7326729B2CXCR1 and CXCR2 chemokine antagonistsSCHERING CORP·Filed 2005·Granted Feb 5, 2008·6 cites·13 claims
- 0678US7691856B2Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·3 cites·67 claims
- 0770US7338968B2Thiadiazoles AS CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 4, 2008·4 cites·46 claims
- 0864US6740661B2Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2001·Granted May 25, 2004·2 cites·23 claims
- 0956US7786149B2Thiadiazoles as CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Aug 31, 2010·0 cites·19 claims
- 1053US2007248594A1Cxcr1 and cxcr2 chemokine antagonistsSCHERING CORP·Filed 2007·Application pending·0 cites
- 1153US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 1252US2004106794A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1349US2004186142A1Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsSCHERING CORP PHARMACOPEIA INC·Filed 2003·Application pending·0 cites
- 1446US2004235908A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1544US2003204085A13, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsFiled 2002·Application pending·0 cites
- 1639US2003097004A13,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1735US2004097547A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →